Objective: To develop evidence based recommendations for the management of ankylosing
spondylitis (AS) as a combined effort of the 'ASsessment in AS'international working group …

Objectives. Although clinicians recognize hip involvement, which frequently leads to hip
replacement surgery, as an important feature of AS, data on the epidemiology, nature of the …

Objective To evaluate the efficacy and safety of ustekinumab in 3 randomized, placebo‐
controlled studies in patients with axial spondyloarthritis (SpA). Studies 1 and 2 included …

Objective To investigate the efficacy and safety of ixekizumab in patients with active
radiographic axial spondyloarthritis (SpA) and prior inadequate response to or intolerance of …

Objectives To create a model that provides a potential basis for candidate selection for anti-
tumour necrosis factor (TNF) treatment by predicting future outcomes relative to the current …

Antiphospholipid Syndrome (APS) is an autoimmune disorder, characterized by pregnancy
morbidity and/or a hyper coagulable state involving the venous or the arterial vasculature …

Background Etoricoxib is a highly selective COX-2 inhibitor which was evaluated for the
treatment of rheumatoid arthritis (RA). Methods Double-blind, randomized, placebo and …

Familial Mediterranean fever (FMF), a recessively inherited autoinflammatory disorder, is the
prototype of a group of disorders termed systemic autoinflammatory diseases. Such …

This first update of the ASAS/EULAR recommendations on the management of ankylosing
spondylitis (AS) is based on the original paper, a systematic review of existing …

Abstract Objective To assess HLA-B27 influence on the clinical phenotype of Ankylosing
Spondylitis (AS) patients. Method An observational, cross-sectional and descriptive study of …